Mechanisms of Photobiomodulation Therapy XII
Proceedings Volume 10048 is from: Logo
28 January - 2 February 2017
San Francisco, California, United States
Front Matter: Volume 10048
Proc. SPIE 10048, Front Matter: Volume 10048, 1004801 (22 March 2017); doi: 10.1117/12.2269861
Mechanisms of Photobiomodulation Therapy I
Proc. SPIE 10048, Photobiomodulation of the brain: a new paradigm (Conference Presentation), 1004802 (19 April 2017); doi: 10.1117/12.2255856
Proc. SPIE 10048, Clinical trial involving sufferers and non-sufferers of cervicogenic headache (CGH): potential mechanisms of action of photobiomodulation (Conference Presentation), 1004803 (19 April 2017); doi: 10.1117/12.2251773
Proc. SPIE 10048, Shining new light on treating dementia: integrating EEG neurofeedback training and near infrared photobiomodulation (Conference Presentation), 1004804 (19 April 2017); doi: 10.1117/12.2256941
Proc. SPIE 10048, Diffuse correlation spectroscopy (DCS) study of blood flow changes during low level laser therapy (LLLT): a preliminary report, 1004806 (17 February 2017); doi: 10.1117/12.2252604
Mechanisms of Photobiomodulation Therapy II
Proc. SPIE 10048, Extraorally delivered photobiomodulation therapy for prevention of oropharyngeal mucositis in pediatric patients undergoing hematopoietic cell transplantation, 1004807 (17 February 2017); doi: 10.1117/12.2256528
Proc. SPIE 10048, The use of laser phototherapy in the management of trigeminal neuralgia pain: two decades of clinical experience, 1004808 (17 February 2017); doi: 10.1117/12.2251176
Proc. SPIE 10048, Biomedical, translational and clinical research on PDT of TMJ, 1004809 (17 February 2017); doi: 10.1117/12.2256070
Mechanisms of Photobiomodulation Therapy III
Proc. SPIE 10048, Clinical translation of photobiomodulation therapy using evidences from precision molecular pathway analyses (Conference Presentation), 100480B (19 April 2017); doi: 10.1117/12.2256307
Mechanisms of Photobiomodulation Therapy IV
Proc. SPIE 10048, Low-level light treatment ameliorates immune thrombocytopenia, 100480E (17 February 2017); doi: 10.1117/12.2256303
Proc. SPIE 10048, Laser-induced immune modulation inhibits tumor growth in vivo (Conference Presentation), 100480F (19 April 2017); doi: 10.1117/12.2257477
Proc. SPIE 10048, 3D Monte Carlo simulation of light propagation for laser acupuncture and optimization of illumination parameters, 100480H (17 February 2017); doi: 10.1117/12.2251312
Proc. SPIE 10048, Effect of LED phototherapy on blood lactate level in Taekwondo contest, 100480I (17 February 2017); doi: 10.1117/12.2252613
Proc. SPIE 10048, Effects of photobiomodulation therapy (pulsed LASER 904 nm) on muscle oxygenation and performance in exercise-induced skeletal muscle fatigue in young women: a pilot study, 100480J (17 February 2017); doi: 10.1117/12.2253585
Proc. SPIE 10048, Photobiomodulation (PBM) with 20 W at 640 nm: pre-clinical results and propagation model, 100480K (17 February 2017); doi: 10.1117/12.2270417
Poster Session
Proc. SPIE 10048, Challenges of transcutaneous laser application for the potential of photobiomodulation of the spinal cord at the scale of a large companion animal, 100480M (17 February 2017); doi: 10.1117/12.2248164
Proc. SPIE 10048, The use of phototherapy in the management of TMJ pain: clinical evidence of benefits and limitations, 100480N (17 February 2017); doi: 10.1117/12.2251179
Proc. SPIE 10048, Evaluation of the efficacy of AmPDT of oral microorganisms with photogem associated to red LED (λ640nm±5nm): in vitro, 100480O (17 February 2017); doi: 10.1117/12.2251181
Proc. SPIE 10048, Investigation on physiological and clinical effects of different light sources in TMJ photobiomodulation therapy, 100480P (17 February 2017); doi: 10.1117/12.2256072
Proc. SPIE 10048, Photonic modulation of EGFR: 280nm low level light arrests cancer cell activation and migration, 100480R (17 February 2017); doi: 10.1117/12.2249038
Back to Top